Sofinnova Investments’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-726,329
| Closed | -$86.5M | – | 69 |
|
2024
Q3 | $86.5M | Buy |
726,329
+76,788
| +12% | +$9.14M | 6.86% | 3 |
|
2024
Q2 | $92.7M | Buy |
649,541
+37,657
| +6% | +$5.38M | 4.82% | 4 |
|
2024
Q1 | $78.6M | Buy |
+611,884
| New | +$78.6M | 4.38% | 6 |
|
2022
Q3 | – | Sell |
-547,746
| Closed | -$30.5M | – | 56 |
|
2022
Q2 | $30.5M | Buy |
+547,746
| New | +$30.5M | 2.54% | 9 |
|
2019
Q3 | – | Sell |
-647,394
| Closed | -$16.5M | – | 72 |
|
2019
Q2 | $16.5M | Buy |
647,394
+151,926
| +31% | +$3.88M | 1.52% | 16 |
|
2019
Q1 | $13M | Buy |
+495,468
| New | +$13M | 1.25% | 16 |
|